Neumora Alternatives & Competitors
12 companies similar to Neumora — Pioneering a new era of medicines for brain diseases
Companies similar to Neumora
Gate Neurosciences
Brain Health, Reimagined
Indianapolis, United Stat...
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Psy Therapeutics
Creating new futures in central nervous system (CNS) treatment and care.
Boston, United States
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
United States
Track all Neumora competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Vigil Neuroscience
Harnessing the power of microglia to transform treatments for neurodegenerative diseases
Watertown, United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Alector
We are on a mission to make brain disorders history.
South San Francisco, Unit...
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
Chase Pharmaceuticals
Pioneering advancements in neuropsychiatric treatment for a brighter future
Deciduous Therapeutics
Deciduous is developing a novel class of immune-modulatory therapies designed to promote a...
San Francisco, United Sta...
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
United States
About Neumora
Neumora, founded in 2020 in the United States, is a pioneering company in the Biotechnology and Health Care industries, with a mission to redefine treatment methodologies for brain diseases. Operating under the slogan, "Pioneering a new era of medicines for brain diseases," Neumora addresses a critical unmet medical ne...
Development of precision medicines for brain diseases, Drug pipeline targeting novel mechanisms of action, Integration of translational, clinical, and computational tools
Patients with brain diseases, Medical professionals in neurology and psychiatry, Healthcare providers focused on CNS disorders
Brain Diseases, Neuroscience, Neuropsychiatric Disorders, Neurodegenerative Diseases, Precision Neuroscience, Novel Mechanisms Of Action, Clinical-stage Biotechnology, Psychiatric Treatments, Neuroscience Drug Development, Data Science Integration, Novel Therapies, Pipeline Development, Therapeutic Innovation, Brain Health, Clinical Programs
B2B, D2C
Product Sales, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Neumora and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Neumora on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
